As of Sept. 30, 2022, BiondVax had cash and cash equivalents of NIS 29.4 million compared to NIS 54 million as of Dec. 31, 2021.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BVXV: